Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of CB-183,315 in Patients With Clostridium Difficile Associated Diarrhea

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Cubist Pharmaceuticals LLC
ClinicalTrials.gov Identifier:
NCT01597505
First received: May 10, 2012
Last updated: June 16, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2015
  Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)